1983
DOI: 10.1677/joe.0.0970319
|View full text |Cite
|
Sign up to set email alerts
|

Oestrogen–bromocriptine interaction in the control of luteinizing hormone and prolactin secretion in the neonatally oestrogenized female rat

Abstract: Neonatally oestrogenized female rats showed hyperprolactinaemia (prolactin, 230 micrograms/l), normal LH levels and absence of a positive feedback effect of oestrogen on secretion of LH at 5 months of age. Bromocriptine treatment for 13 days (1 mg/kg per day) caused no changes in LH levels and prolactin levels decreased to normal values (33 micrograms/l). This decrease in prolactin concentration was not followed by the recovery of phasic LH response to oestrogens. The effectiveness of oestrogens to induce prol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

1986
1986
2009
2009

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 26 publications
1
4
0
Order By: Relevance
“…The alterations induced by neonatal administration of TP or OeB (acyclicity, anovulation, ovarian atrophy, and loss of negative and positive feedback between oestradiol and LH) are in accordance with a number of previous studies (Barraclough 1961, Gorski 1963, Mennin & Gorski 1975, Aguilar et al 1983. In addition, postnatal treatment of female rats with antioestrogens, such as ICI-628 or MER-25, has been shown to interfere with hypothalamic feminization (McEwen et al 1977, Döhler & Hancke 1978 and to prevent hypothalamic masculinization by oestrogens or androgens (Döhler & Hancke 1978).…”
Section: Discussionsupporting
confidence: 91%
“…The alterations induced by neonatal administration of TP or OeB (acyclicity, anovulation, ovarian atrophy, and loss of negative and positive feedback between oestradiol and LH) are in accordance with a number of previous studies (Barraclough 1961, Gorski 1963, Mennin & Gorski 1975, Aguilar et al 1983. In addition, postnatal treatment of female rats with antioestrogens, such as ICI-628 or MER-25, has been shown to interfere with hypothalamic feminization (McEwen et al 1977, Döhler & Hancke 1978 and to prevent hypothalamic masculinization by oestrogens or androgens (Döhler & Hancke 1978).…”
Section: Discussionsupporting
confidence: 91%
“…In fact the hyperprolactinaemia in SH rats is accompanied by increased plasma concentrations of FSH (Amador et al 1983), while the greater increase in prolactin levels in grafted or tumour-bearing rats suppress gonadotrophin secretion (Bartke, Smith, Michael et al 1977;Hodson, Simpkins, Pass et al 1980). In addition, in neonatally oestrogenized adult female rats, hyperprolactinaemia with high (Vaticón, Aguilar, Fernandez-Galaz & Tejero, 1980) or normal (Aguilar, Fernandez-Galaz, Vaticón et al 1983) plasma levels of LH have been reported.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, perinatal life is the period of greatest sensitivity to the organizing effects of gonadal steroids [8,14], and large doses of estrogens given s.c. to neonate rats result in neuroendocrine alterations [15,16] that resemble those observed in spontaneously aging females already in constant estrus [6,7]. Thus, to reproduce the conditions that cause early reproductive senescence, small doses of steroids have been administered early in life with the result that the animals displayed regular estrus cycles after puberty but soon failed to ovulate [14,[17][18][19].…”
Section: Introductionmentioning
confidence: 99%
“…Based on this hypothesis, a first alternative approach was therefore designed to determine whether a controlled neonatal exposure to a large dose of E 2 by means of implants is sufficient to improve the results obtained with low doses by s.c. injections. Thus, to assess the optimal duration of the treatment that will lead to DAS, we examined the effects of gradual reduction of EB exposure time, using a dose (100 pLg) previously shown to produce a full anovulatory syndrome when given s.c. [15,16,20].…”
Section: Introductionmentioning
confidence: 99%